Literature DB >> 22726608

The pros and cons of chemokines in tumor immunology.

Antonella Viola1, Adelaida Sarukhan, Vincenzo Bronte, Barbara Molon.   

Abstract

Innate and adaptive immune cells can intervene during tumor progression at different stages including initiation, angiogenesis, local spreading and distant metastasis formation. The net effect can be favorable or detrimental to tumor development, depending on the composition and activation status of the immune infiltrate. Chemokines can determine the distribution of immune cells in the tumor microenvironment and also affect stroma composition. Here we consider how a complex network of chemokines plays a key role in dictating the fate of a tumor. Although the field is in its infancy, we also highlight how targeting chemokines offers a tool to modulate the tumor environment with the aim of enhancing immune-mediated rejection of cancer.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22726608     DOI: 10.1016/j.it.2012.05.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  49 in total

Review 1.  Neutrophils in the Tumor Microenvironment.

Authors:  Davalyn R Powell; Anna Huttenlocher
Journal:  Trends Immunol       Date:  2015-12-14       Impact factor: 16.687

2.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

Review 3.  Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.

Authors:  Catherine J Hutchings; Markus Koglin; William C Olson; Fiona H Marshall
Journal:  Nat Rev Drug Discov       Date:  2017-07-14       Impact factor: 84.694

4.  Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.

Authors:  Renata Boldrini; Maria Debora De Pasquale; Ombretta Melaiu; Marco Chierici; Giuseppe Jurman; Maria Chiara Benedetti; Nunzio C Salfi; Aurora Castellano; Paola Collini; Cesare Furlanello; Vito Pistoia; Loredana Cifaldi; Monica Terenziani; Doriana Fruci
Journal:  Oncoimmunology       Date:  2018-12-13       Impact factor: 8.110

5.  CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.

Authors:  Hangyi H Yan; Jian Jiang; Yanli Pang; B R Achyut; Michael Lizardo; Xinhua Liang; Kent Hunter; Chand Khanna; Christine Hollander; Li Yang
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

6.  Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.

Authors:  Denarda Dangaj; Marine Bruand; Alizée J Grimm; Catherine Ronet; David Barras; Priyanka A Duttagupta; Evripidis Lanitis; Jaikumar Duraiswamy; Janos L Tanyi; Fabian Benencia; Jose Conejo-Garcia; Hena R Ramay; Kathleen T Montone; Daniel J Powell; Phyllis A Gimotty; Andrea Facciabene; Donald G Jackson; Jeffrey S Weber; Scott J Rodig; Stephen F Hodi; Lana E Kandalaft; Melita Irving; Lin Zhang; Periklis Foukas; Sylvie Rusakiewicz; Mauro Delorenzi; George Coukos
Journal:  Cancer Cell       Date:  2019-06-10       Impact factor: 31.743

7.  Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.

Authors:  Daniel W Beury; Katherine H Parker; Maeva Nyandjo; Pratima Sinha; Kayla A Carter; Suzanne Ostrand-Rosenberg
Journal:  J Leukoc Biol       Date:  2014-08-28       Impact factor: 4.962

Review 8.  Regulation of chemokine expression in the tumor microenvironment.

Authors:  Anton V Gorbachev; Robert L Fairchild
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

9.  CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.

Authors:  Xi Zhu; Yan Qiao; Weihua Liu; Wenying Wang; Hongliang Shen; Yi Lu; Gangyue Hao; Jiajia Zheng; Ye Tian
Journal:  Tumour Biol       Date:  2015-10-27

Review 10.  Restriction of drug transport by the tumor environment.

Authors:  Rajender Nandigama; Berin Upcin; Bertal H Aktas; Süleyman Ergün; Erik Henke
Journal:  Histochem Cell Biol       Date:  2018-10-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.